Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06905912 · ClinicalTrials.gov registry record · NA
Comparison Between Spectacles and Contact Lenses
A NA study of Photophobia, sponsored by University of Oklahoma.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT06905912: Recruiting NA study of Photophobia, sponsored by University of Oklahoma.
NCT06905912 is a NA study of Photophobia that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 200 participants, above the 59-participant average among 3 other Photophobia trials with a reported enrollment target (239% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06905912, a NA study of Photophobia, is actively recruiting participants, sponsored by University of Oklahoma.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Many people suffer from migraine headaches, some more so than others and a common trigger/complaint is light sensitivity, or photophobia1. Some will go to great lengths to avoid light: a dark room with sunglasses on and blankets over the windows, often missing work/school/social activities, etc. Several ocular conditions are accompanied by photophobia, ranging from mild to debilitating.
Primary Outcome
questionnaires - scale of 1 to 10 - no light sensitivity and 10 extreme light sensitivity
Conditions Studied
Interventions
- DEVICE Biomedics55 Premier contact lenses, and Altius Tinted Contact Lenses
Study Locations (1)
Oklahoma
- Dean McGee Eye Institute - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-12-10 |
| Est. Completion | 2025-09-01 |
| Phase | NA |
What NCT06905912 shows while recruiting
NCT06905912 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 59-participant average among 3 other Photophobia trials with a reported enrollment target (239% higher).
The record links to 1 condition, with Photophobia appearing as the primary indexed condition, and to 1 intervention - of which Biomedics55 Premier contact lenses, and Altius Tinted Contact Lenses is the first listed.
NCT06905912 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT06905912 about?
NCT06905912 is a clinical study titled "Comparison Between Spectacles and Contact Lenses". Many people suffer from migraine headaches, some more so than others and a common trigger/complaint is light sensitivity, or photophobia1. Some will go to great lengths to avoid light: a dark room with sunglasses on and blankets over the windows, often missing work/school/social activities, etc. Sev...
What is the current status of trial NCT06905912?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-12-10. Estimated completion is 2025-09-01.
What conditions does trial NCT06905912 study?
This clinical trial studies the following conditions: Photophobia.
What interventions are being tested in trial NCT06905912?
The interventions under investigation include: Biomedics55 Premier contact lenses, and Altius Tinted Contact Lenses (DEVICE).
Who is sponsoring clinical trial NCT06905912?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06905912 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Photophobia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI